Sign Out
Pregnancy and lactation: The safety of Iodixanol for use in human pregnancy has not been established. An evaluation of experimental animal studies does not indicate direct or indirect harmful effects with respect to reproduction, development of the embryo or fetus, the course of gestation and peri- and postnatal development.
Since, wherever possible, radiation exposure should be avoided during pregnancy, the benefits of any X-ray examination, with or without contrast media, should be carefully weighed against the possible risk. The product should not be used in pregnancy unless benefit outweighs risk and it is considered essential by the physician.
The degree of excretion into human milk is not known, although expected to be low. Breast feeding should be discontinued prior to administration of Iodixanol and should not be recommenced until at least 24 hours after.
